Clinical Trials Logo
  1. Home
  2. Heart Failure Acute
  3. NCT03169803

Cardiac Output Autonomic Stimulation Therapy for Acute Heart Failure (COAST-AHF)

Heart Failure Acute Clinical Trial

Official title:
Cardiac Output Autonomic Stimulation Therapy for Acute Heart Failure (COAST-AHF) - System Design Study

Clinical Trial Summary

A feasibility study to investigate the safety and performance of the NeuroTronik Cardiac Autonomic Nerve Stimulation (CANS) Therapy System

Clinical Trial Description

A single-arm, safety study intended to assess safety and system performance, and the feasibility to improve hemodynamics in patients with acute heart failure syndrome using transvenous, cardiac autonomic nerve stimulation (CANS) therapy. In addition, the effects of NeuroTronik CANS Therapy™ on the congestion of patients will be studied. The study proposes that the NeuroTronik CANS Therapy™ System be deployed during the acute heart failure syndrome hospital admission, along with existing standard treatment. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03169803
Study type Interventional
Source NeuroTronik Inc.
Contact Temístocles Díaz, MD
Phone +507.204.8354
Email hemcicompany@gmail.com
Status Recruiting
Phase N/A
Start date May 19, 2017
Completion date June 19, 2019
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04080388 - How to Prevent Heart Failure Readmission by Using Lung Impedance Device (HOPE-HF Study) Phase 3
Recruiting NCT04751838 - Development and Validation of a Simple-to-use Nomogram for Predicting In-hospital Mortality in Acute Heart Failure Patients Undergoing Continuous Renal Replacement Therapy
Active, not recruiting NCT04618601 - Diuretic and Natriuretic Effect of High-dose Spironolactone in Patients With Acute Heart Failure Phase 4
Recruiting NCT06142474 - SGLT2 Inhibitors in Patients With ADHF During Ventilator Weaning Phase 3
Active, not recruiting NCT05603247 - The SWISSHEART Failure Network (SHFN)
Not yet recruiting NCT06273397 - Acetazolamide or Metolazone in Acute Heart Failure N/A
Recruiting NCT03542123 - Cardiac Output Autonomic Stimulation Therapy for Heart Failure - Hemodynamic Effects N/A
Completed NCT04878263 - Evaluation and Support Care Process Within the Care Pathway of Heart Failure Patients N/A
Not yet recruiting NCT06442280 - SGLT-2 Inhibitor and High-Dose Furosemide Plus Small-Volume Hypertonic Saline Solution in Acute HF Phase 4
Completed NCT04281849 - Balance, Aerobic Capacity, Mobility and Strength in Patients Hospitalized for Heart Failure (BAMS-HF) Program N/A
Not yet recruiting NCT04403659 - Telemonitoring of Patients Admitted in Hospital at Home With Acute Decompensated Heart Failure - Pilot Study N/A
Terminated NCT03574857 - Prospective Comparison of Metolazone Versus Chlorothiazide for Acute Decompensated Heart Failure With Diuretic Resistance Phase 4
Completed NCT03136198 - B-lines Lung Ultrasound Guided ED Management of Acute Heart Failure Pilot Trial Phase 2
Terminated NCT03746002 - Diuretic Effect of Metolazone Pre-dosing Versus Concurrent Dosing Phase 4
Active, not recruiting NCT03513653 - Strain for Risk Assessment and Therapeutic Strategies in Patients With Acute Heart Failure (STRATS-AHF) Registry
Recruiting NCT06092437 - Investigating a Tailored Diuretic Algorithm in Acute Heart Failure Patients N/A
Recruiting NCT05746923 - Lesser Poland Cracovian Heart Failure Registry
Recruiting NCT06414928 - Prognostic Model Heart Failure
Completed NCT04606927 - Pragmatic Urinary Sodium-based Treatment algoritHm in Acute Heart Failure N/A
Completed NCT03200860 - Effects of Empagliflozin on Clinical Outcomes in Patients With Acute Decompensated Heart Failure Phase 2